Log In
Print
BCIQ
Print
Print this Print this
 

Xience V (Promus)

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionEverolimus-eluting coronary stent system utilizing a durable polymer
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today